This inventor holds 2 USPTO granted patents. Top assignee: Cadila Healthcare Limited. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ahmedabad, IN (2014)
- Gujarat, IN (2016)
Company Filing History:
Years Active: 2014-2016
Title: Dhaval Jashvantbhai Patel: Innovator in Pharmaceutical Processes
Introduction
Dhaval Jashvantbhai Patel is a notable inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug preparation. With a total of 2 patents to his name, Patel's work is recognized for its innovation and impact on healthcare.
Latest Patents
Patel's latest patents include a method for the preparation of sitagliptin phosphate. This invention relates to the synthesis of sitagliptin phosphate and its anhydrous and monohydrate forms. Another significant patent is for an improved process for preparing substituted Fluticasone derivatives. This invention also details the purification processes for Fluticasones and related intermediates, ensuring the production of highly pure products.
Career Highlights
Patel is currently associated with Cadila Healthcare Limited, a prominent player in the pharmaceutical industry. His work at the company focuses on innovative drug development and process optimization. His contributions have been instrumental in advancing the company's research and development efforts.
Collaborations
Throughout his career, Patel has collaborated with several professionals, including Kirtipalsinh Sajjansinh Solanki and Shri Prakash Dhar Dwivedi. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical processes.
Conclusion
Dhaval Jashvantbhai Patel exemplifies the spirit of innovation in the pharmaceutical industry. His patents and contributions significantly enhance drug preparation methods, ultimately benefiting healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
